Gene therapy with adenovirus-mediated VEGF enhances skin flap prefabrication

Microsurgery

Volumn 25, Issue 5, 2005, Pages 433-441

  Gurunluoglu, Raffi ^a   Meirer, Romed ^b,c   Shafighi, Maziar ^b,c   Huemer, Georg M ^b,c   Yilmaz, Berkhan ^a   Piza Katzer, Hildegunde ^b,c  

^a Acibadem Hospital   (Turkey)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; SODIUM CHLORIDE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DONOR SITE; FEASIBILITY STUDY; FOLLOW UP; GENETIC TRANSFECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; ISLAND FLAP; MALE; MICROANGIOGRAPHY; MICROVASCULARIZATION; NONHUMAN; PEDICLED SKIN FLAP; PRIORITY JOURNAL; RAT; SKIN BIOPSY; SKIN BLOOD FLOW; SURGICAL TECHNIQUE; SURVIVAL RATE; SUTURING METHOD; TISSUE SECTION; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; GENE THERAPY; GENETIC VECTORS; MALE; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; SKIN TRANSPLANTATION; SURGICAL FLAPS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 23244444179     PISSN: 07381085     EISSN: None     Source Type: Journal    
DOI: 10.1002/micr.20142     Document Type: Article

References (56)

1. Khouri RK, Upton J, Shaw WW. Principles of flap prefabrication. Clin Plast Surg 1992;19:763-771.
2. Abbase EA, Shenaq SM, Spira M, el-Falaky MH. Prefabricated flaps: experimental and clinical review. Plast Reconstr Surg 1995;96:1218-1225.
3. Vineberg AM. Development of an anastomosis between the coronary vessels and a transplanted internal mammary artery. Can Med Assoc J 1946;55:117-119.
4. Erol OO. The transformation of a free skin graft into a vascularized pedicled flap. Plast Reconstr Surg 1976;58:470-477.
5. Yao ST. Vascular implantation into a skin flap: experimental study and clinical application. A preliminary report. Plast Reconstr Surg 1981;68:404-409.
6. Erol OO, Spira M. Development and utilization of a composite island flap employing omentum: experimental investigation. Plast Reconstr Surg 1980;65:405-418.
7. Erol OO, Spira M. Utilization of a composite island flap employing omentum in organ reconstruction: an experimental investigation. Plast Reconstr Surg 1981;68:561-570.
8. Erol OO, Spira M. Secondary musculocutaneous flap: an experimental study. Plast Reconstr Surg 1980;65:277-282.
9. Tark KC, Khouri RK, Shin KS, Shaw WW. The fasciovascular pedicle for neovascularization of the other tissues. Ann Plast Surg 1991;26:149-155.
10. Khouri RK, Upton J, Shaw WW. Prefabrication of composite free flaps through staged microvascular transfer: an experimental and clinical study. Plast Reconstr Surg 1991;87:l08-l15.
11. Khouri RK, Özbek MR, Hruza GJ, Young VL. Facial reconstruction with prefabricated induced expanded (PIE) supraclavicular skin flaps. Plast Reconstr Surg 1995;95:1006-1015.
12. Ozerdem OR, Anlatici R, Sen O, Yildirim T, Bircan S, Aydin M. Prefabricated galeal flap based on superficial temporal and posterior auricular vessels. Plast Reconstr Surg 2003;111:2166-2175.
13. Zhang F, Waller W, Lineaweaver WC. Growth factors and flap survival. Microsurgery 2004;24:162-167.
14. Padubidri A, Browne E Jr. Effect of vascular endothelial growth factor (VEGF) on survival of random extension of axial pattern skin flaps in the rat. Ann Plast Surg 1996;37:604-611.
15. Hopkins SP, Bulgrin JP, Sims RL, Bowman B, Donovan DL, Schmidt SP. Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia. J Vasc Surg 1998;27:886-894.
16. Kryger Z, Dogan T, Zhang F, Komorowska-Timek E, Shi DY, Cheng C, Lineaweaver WC, Buncke HJ. Effects of VEGF administration following ischemia on survival of the gracilis muscle flap in the rat. Ann Plast Surg 1999;43:172-178.
17. Kryger Z, Zhang F, Dogan T, Cheng C, Lineaweaver WC, Buncke HJ. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br J Plast Surg 2000;53:234-239.
18. Banbury J, Siemionow M, Porvasnik S, Petras S, Browne E. Improved perfusion after subcritical ischemia in muscle flaps treated with vascular endothelial growth factor. Plast Reconstr Surg 2000;106:1541-1546.
19. Zhang F, Fischer K, Komorowska-Timek E, Guo M, Cui D, Dorsett-Martin W, Buncke HJ, Lineaweaver WC. Improvement of skin paddle survival by application of vascular endothelial growth factor in a rat TRAM flap model. Ann Plast Surg 2001;46:314-319.
20. Zhang F, Richards L, Angel MF, Zhang J, Liu H, Dorsett-Martin W, Lineaweaver WC. Accelerating flap maturation by vascular endothelium growth factor in a rat tube flap model. Br J Plast Surg 2002;55:59-63.
21. Seify H, Bilkay U, Jones G. Improvement of TRAM flap viability using human VEGF-induced angiogenesis: a comparative study of delay techniques. Plast Reconstr Surg 2003;112:1032-1039.
22. Khouri RK, Brown DM, Leal-Khouri SM, Tark KC, Shaw WW. The effect of basic fibroblast growth factor on the revascularization process: skin flap survival and staged flap transfers. Br J Plast Surg 1991;44:585-588.
23. Ishiguro N, Yabe Y, Shimizu T, Iwata H, Miura T. Basic fibroblast growth factor has a beneficial effect on the viability of random skin flaps in rats. Ann Plast Surg 1994;32:356-360.
24. Carroll SM, Carroll CM, Stremel RW, Heilman SJ, Steffen JM, Tobin GR, Barker JH. Vascular delay and administration of basic fibroblast growth factor augment latissimus dorsi muscle flap perfusion and function. Plast Reconstr Surg 2000;105:964-971.
25. Huemer GM, Shafighi M, Meirer R, Debagge P, Piza-Katzer H, Gurunluoglu R. Adenovirus-mediated transforming growth factor-beta ameliorates ischemic necrosis of epigastric skin flaps in a rat model. J Surg Res 2004;121:101-107.
26. Gurunluoglu R, Lubiatowski P, Goldman CK, Carnevale K, Siemionow M. Enhancement of muscle flap hemodynamics by angiopoietin-1. Ann Plast Surg 2002;48:401-409.
27. Jung H, Gurunluoglu R, Scharpf J, Siemionow M. Adenovirus-mediated angiopoietin-1 gene therapy enhances skin flap survival. Microsurgery 2003;23:374-380.
28. Eming SA, Morgan JR, Berger A. Gene therapy for tissue repair approaches and prospects. Br J Plast Surg 1997;50:491-500.
29. Taub PJ, Silver L, Weinberg H. Plastic surgical perspectives on vascular endothelial growth factor as gene therapy for angiogenesis. Plast Reconstr Surg 2000;105:1034-1042.
30. Magovern CJ, Mack CA, Zhang J, Hahn RT, Ko W, Isom OW, Crystal RG, Rosengart TK. Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector. Ann Thorac Surg 1996;62:425-433.
31. Maeda Y, Ikeda U, Shimpo M, Shibuya M, Monahan J, Urabe M, Ozawa K, Shimada K. Adeno-associated virus-mediated vascular endothelial growth factor gene transfer into cardiac myocytes. J Cardiovasc Pharamcol 2000;36:438-443.
32. Zhang D, Gai L, Fan R, Dong W, Wen Y. Efficacy and safety of therapeutic angiogenesis from direct myocardial administration of an adenoviral vector expressing vascular endothelial growth factor 165. Chin Med J [Engl] 2002;115:643-648.
33. Retuerto MA, Schalch P, Patejunas G, Carbray J, Liu N, Esser K, Crystal RG, Rosengart TK. Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation. J Thorac Cardiovasc Surg 2004;127:1041-1049.
34. Mack CA, Magovern CJ, Budenbender KT, Patel SR, Schwarz EA, Zanzonico P, Ferris B, Sanborn T, Isom P, Ferris B, Sanborn T, Isom OW, Crystal RG, Rosengart TK. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J Vasc Surg 1998;27:699-709.
35. Shimpo M, Ikeda U, Maeda Y, Takahashi M, Miyashita H, Mizukami H, Urabe M, Kume A, Takizawa T, Shibuya M, Ozawa K, Shimada K. AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model. Cardiovasc Res 2002;53:993-1001.
36. Hershey JC, Baskin EP, Corcoran HA, Bett A, Dougherty NM, Gilberto DB, Mao X, Thomas KA, Cook JJ. Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits. Heart Vessels 2003;18:142-149.
37. Lubiatowski P, Gurunluoglu R, Goldman CK, Skugor B, Carnevale K, Siemionow M. Gene therapy by adenovirus-mediated vascular endothelial growth factor and angiopoietin-1 promotes perfusion of muscle flaps. Plast Reconstr Surg 2002;110:149-159.
38. Lubiatowski P, Goldman CK, Gurunluoglu R, Carnevale K, Siemionow M. Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy. Plast Reconstr Surg 2002;109:1986-1993.
39. Gurunluoglu R, Ozer K, Skugor B, Lubiatowski P, Carnevale K, Siemionow M. Effect of transfection time on the survival of epigastric skin flaps pretreated with adenovirus encoding the VEGF gene. Ann Plast Surg 2002;49:161-169.
40. Gurunluoglu R, Bayramicli M, Dogan T, Cakalagaoglu F, Numanoglu A. Use of fascial grafts as an interface in flap prefabrication: an experimental study. Ann Plast Surg 1999;43:42-48.
41. Dogan T, Gurunluoglu R, Bayramicli M, Numanoglu A. Use of a polyfilament suture as a source of microsuture. Plast Reconstr Surg 1998;102:270-271.
42. Iwasawa M. Accelerated maturation in prefabricated flaps by transforming growth factor-beta: an experimental study in the rabbit. Ann Plast Surg 1993;31:72-75.
43. Haws MJ, Erdman D, Bayati S, Brown RE, Russell RC. Basic fibroblast growth factor induced angiogenesis and prefabricated flap survival. J Reconstr Microsurg 2001;17:39-42.
44. Li QF, Reis ED, Zhang WX, Silver L, Fallon JT, Weinberg H. Accelerated flap prefabrication with vascular endothelial growth factor. J Reconstr Microsurg 2000;16:45-49.
45. Shima DT, Deutsch U, D'Amore PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 1995;370:203-208.
46. Yla-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000;355:213-222.
47. Patel SR, Lee LY, Mack CA, Polce DR, El-Sawy T, Hackett NR, Ilercil A, Jones EC, Hahn RT, IsomO W, Rosengart TK, Crystal RG. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. Hum Gene Ther 1999;10:1331-1348.
48. Zhang D, Gai L, Fan R, Dong W, Wen Y. Efficacy and safety of therapeutic angiogenesis from direct myocardial administration of an adenoviral vector expressing vascular endothelial growth factor 165. Chin Med J [Engl] 2002;115:643-648.
49. Mohler ER III, Rajagopalan S, Olin JW, Trachtenberg JD, Rasmussen H, Pak R, Crystal RG. Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase 1 trial. Vasc Med 2003;8:9-13.
50. Newman KD, Dunn PF, Owens JW, Schulick AH, Virmani R, Sukhova G, Libby P, Dichek DA. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 1995;96:2955-2965.
51. Tripathy SK, Black HB, Goldwasser E, Leiden JM. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 1996;2:545-550.
52. Lehrman S. Virus treatment questioned after gene therapy death. Nature 1999;401:517-518.
53. Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999;100:468-474.
54. Rosengart TK, Lee LY, Patel SR, Kligfield PD, Okin PM, Hackett NR, Isom OW, Crystal RG. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg 1999;230:466-470.
55. Hedman M, Hartikainen J, Syvanne M, Stjernvall J, Hedman A, Kivela A, Vanninen E, Mussalo H, Kauppila E, Simula S, Narvanen O, Rantala A, Peuhkurinen K, Nieminen MS, Laakso M, Yla-Herttuala S. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003;107:2677-2683.
56. Makinen K, Manninen H, Hedman M, Matsi P, Mussalo H, Alhava E, Yla-Herttuala S. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther 2002;6:127-133.